Pulsed field ablation (PFA) Marshall plan including Marshall vein ethanol infusion approach in primary intent for persistent atrial fibrillation treatment

医学 肺静脉 心房颤动 烧蚀 心脏病学 外科 内科学 射血分数 导管消融 静脉 前瞻性队列研究 心力衰竭 窦性心律 心脏消融
作者
Alfredo da Costa,M. Murat,Cédric Yvorel,Cécile Romeyer,Rayan Mohammed,Karim Bénali
出处
期刊:European Heart Journal [Oxford University Press]
卷期号:46 (Supplement_1)
标识
DOI:10.1093/eurheartj/ehaf784.826
摘要

Abstract Background Different ablation strategies and energies have been developed for persistent atrial fibrillation (PeAF) treatment, but early management is still controversial. In the clinical setting of PeAF, the safety and efficacy of early Marshall plan combined with pulsed field ablation (PFA) and vein of Marshall ethanol infusion (VOMEI) have not yet been evaluated. Objectives Our prospective cohort study sought to: (1) assess the safety and feasibility of the non-thermal Marshall plan approach combined with VOMEI (Marshall plan VOMEI) as a first-line therapy in PeAF patients; (2) evaluate its mid-term efficacy. Methods and Results Between November 2023 and February 2025, 55 PeAF patients were referred for Marshall plan VOEMI. The Marshall Plan sequences were implemented as follows: VOEMI first followed by left pulmonary vein isolation (PVI), then mitral plus roof lines, and then right PVI; lastly the roof line and the mitral line were once again checked. The Farapulse system was used for PFA ablation. Marshall vein failure occurred in 4/55 patients (7.3%). Fifty-one pts (92.7%) who underwent Marshall plan VOEMI as first-line therapy were included. Their clinical and echocardiographic characteristics were as follows: mean age of 70±7.6 years, 23.5% of women, mean CHA²DS²VA score of 2.9±1.7, mean left ventricular ejection fraction of 57±14%, and mean left atrial size of 26±4cm² and volume (52±22 ml/m²). Procedure steps duration (min) and X-ray exposure (min) were as follows: skin to skin procedure (47±12 and 14.4±4.7 min); VOMEI duration (10.4±3.7 and 3.6±2.4 min); transeptal puncture (4.9±3 and 2.5±2.1 min) and PFA (21.1±6.5 and 7.5±2 min). The total number of PFA applications was 60±7.6, 38±4 for PVI, 10±3 for roof line and 14±6 for the mitral line. The % of mitral line recurrence at the procedure end was 43% despite VOMEI. Accordingly, repeated new applications were required until the mitral line block was obtained. No complications occurred. At mid-term FU (6.5±3 months), freedom from any atrial arrhythmia was 80.4%. Recurrences were as follows: PeAFib in 4, paroxysmal AFib in 4, left atrial flutter in 1 and right atrial flutter in 1. Conclusions This real-life prospective cohort study showed that de novo PFA Marshall plan plus VOEMI in PeAF is feasible, safe, but associated with a high rate of acute mitral line block recovery (43%). Mid-term freedom from any atrial arrhythmia recurrences is close to 80%.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
CAOHOU的应助被吱吱采纳,获得10
1秒前
1秒前
3秒前
5秒前
drleslie完成签到 ,获得积分10
6秒前
Alexlovar发布了新的文献求助30
7秒前
7秒前
凯旋归来完成签到 ,获得积分10
7秒前
7秒前
8秒前
zhanzhanzhan发布了新的文献求助20
8秒前
9秒前
路小雨发布了新的文献求助10
10秒前
蒋莹萱完成签到 ,获得积分10
10秒前
简单的浩然完成签到,获得积分10
11秒前
11秒前
11秒前
wangyuu关注了科研通微信公众号
11秒前
活力孤菱完成签到,获得积分10
12秒前
nxdr发布了新的文献求助10
13秒前
英姑的应助被曾经的路灯采纳,获得10
13秒前
dxt发布了新的文献求助10
13秒前
卡皮巴拉完成签到 ,获得积分10
14秒前
GTR的我完成签到 ,获得积分10
14秒前
等风归发布了新的文献求助10
15秒前
Xy完成签到,获得积分10
15秒前
yu发布了新的文献求助10
15秒前
Akim的应助被饼饼采纳,获得10
16秒前
彭于晏的应助被unicornmed采纳,获得10
16秒前
复杂的悟空完成签到,获得积分10
16秒前
Alexlovar完成签到,获得积分20
17秒前
19秒前
Alicyclobacillus完成签到,获得积分10
20秒前
我爱科研科研爱我完成签到,获得积分10
23秒前
24秒前
小蘑菇的应助被陈小黑采纳,获得10
24秒前
25秒前
ly完成签到,获得积分10
25秒前
26秒前
ref:rain完成签到 ,获得积分10
27秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Boundaries and Bodhisattvas 500
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8181839
求助须知:如何正确求助?哪些是违规求助? 9571584
关于积分的说明 21818707
捐赠科研通 7778124
什么是DOI,文献DOI怎么找? 3433524
关于科研通互助平台的介绍 2557710
邀请新用户注册赠送积分活动 2479621